Walitt Brian, Nahin Richard L, Katz Robert S, Bergman Martin J, Wolfe Frederick
National Center for Complementary and Integrative Health, National Institutes of Health, Bethesda, Maryland, United States of America.
Rush University Medical Center, Chicago, IL, United States of America.
PLoS One. 2015 Sep 17;10(9):e0138024. doi: 10.1371/journal.pone.0138024. eCollection 2015.
Most knowledge of fibromyalgia comes from the clinical setting, where healthcare-seeking behavior and selection issues influence study results. The characteristics of fibromyalgia in the general population have not been studied in detail.
We developed and tested surrogate study specific criteria for fibromyalgia in rheumatology practices using variables from the US National Health Interview Survey (NHIS) and the modification (for surveys) of the 2010 American College of Rheumatology (ACR) preliminary fibromyalgia criteria. The surrogate criteria were applied to the 2012 NHIS and identified persons who satisfied criteria from symptom data. The NHIS weighted sample of 8446 persons represents 225.7 million US adults.
Fibromyalgia was identified in 1.75% (95% CI 1.42, 2.07), or 3.94 million persons. However, 73% of identified cases self-reported a physician's diagnosis other than fibromyalgia. Identified cases had high levels of self-reported pain, non-pain symptoms, comorbidity, psychological distress, medical costs, Social Security and work disability. Caseness was associated with gender, education, ethnicity, citizenship and unhealthy behaviors. Demographics, behaviors, and comorbidity were predictive of case status. Examination of the surrogate polysymptomatic distress scale (PSD) of the 2010 ACR criteria found fibromyalgia symptoms extending through the full length of the scale.
Persons identified with criteria-based fibromyalgia have severe symptoms, but most (73%) have not received a clinical diagnosis of fibromyalgia. The association of fibromyalgia-like symptoms over the full length of the PSD scale with physiological as well as mental stressors suggests PSD may be a universal response variable rather than one restricted to fibromyalgia.
纤维肌痛的大多数知识来源于临床环境,在该环境中,寻求医疗行为和选择问题会影响研究结果。普通人群中纤维肌痛的特征尚未得到详细研究。
我们利用美国国家健康访谈调查(NHIS)中的变量以及对2010年美国风湿病学会(ACR)纤维肌痛初步标准的修改(用于调查),制定并测试了风湿病实践中纤维肌痛的替代研究特定标准。将替代标准应用于2012年NHIS,并从症状数据中识别出符合标准的人员。NHIS中8446人的加权样本代表2.257亿美国成年人。
识别出纤维肌痛患者1.75%(95%置信区间1.42, 2.07),即394万人。然而,73%的已识别病例自我报告有除纤维肌痛之外的医生诊断。已识别病例自我报告的疼痛、非疼痛症状、合并症、心理困扰、医疗费用、社会保障和工作残疾水平较高。病例状态与性别、教育程度、种族、公民身份和不健康行为有关。人口统计学、行为和合并症可预测病例状态。对2010年ACR标准的替代多症状困扰量表(PSD)进行检查发现,纤维肌痛症状贯穿整个量表。
通过基于标准识别出的纤维肌痛患者有严重症状,但大多数(73%)未得到纤维肌痛的临床诊断。PSD量表全长上类似纤维肌痛症状与生理和心理应激源的关联表明,PSD可能是一个普遍的反应变量,而非仅限于纤维肌痛。